Atlas Trials

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

Clinical trial NCT00321932 · COMPLETED

Trial details

NCT number
NCT00321932
Sponsor
University of Minnesota
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMyelodysplastic SyndromesOsteoporosisOvarian Cancer
Start date
2005-07-01
Primary completion
2011-03-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.